Home > Boards > US OTC > Computers - Software >

Appyea, Inc. (APYP)

Add APYP Price Alert      Hide Sticky   Hide Intro
Moderator: Raphael De La Ghetto, YeralHax, GOLDBUFFALO, ThoughtPower, plutoniumimplosion, nuffmoney
Search This Board: 
Last Post: 1/19/2019 11:35:30 AM - Followers: 191 - Board type: Free - Posts Today: 0

APPYEA Game and Mobile App Development
Premium Apps for Business and Gaming

Share Structure

Market Cap
Authorized Shares
Outstanding Shares
Current news regarding Appyea subsidiary The Diagnostic Centers, Inc.

AppYea Signs Sales and Marketing Agreement with Syncier BioTech

FORT WORTH, TX -- (Marketwired) -- 11/28/17 -- AppYea, Inc, (OTC PINK: APYP) announced today that its subsidiary, The Diagnostic Centers, has entered into a sales and Marketing Agreement with Syncier BioTech Inc. to strengthen its Pharmacogenetic ("PGx") testing capabilities and service offerings.

Syncier offers a suite of comprehensive genetic tests including (i) cancer pre-disposition, which provides patients a strong understanding of whether they have an increased risk of developing certain cancers, (ii) patient's tolerance and effects of prescription drugs, which shows how a patient's genes respond to different prescription drugs allowing the physician to tailor a patient's treatment with safe effective drugs, (iii) blood wellness, which helps determine a patient's overall wellness and understand what's going on inside the body at a metabolic level and (iv) respiratory pathogen tests which help a physician understand which pathogen is effecting the patient's respiratory.

PGx testing provides insight into a patient's metabolic pathways. Knowing which pathways are functioning normally or abnormally allows a physician to prescribe medications as intended by the drug manufacturer, select the most appropriate dose, and even the best drug for the patient.

"We continue to look for advanced products and service that we can market to our doctor groups and clinics. With the ability to offer these advanced tests we can attract a broader base of healthcare providers," said Douglas McKinnon, AppYea's CEO. "Additionally, PGx testing is a much higher revenue generator than basic blood and toxicology test, resulting in increased margins."


AppYea's Subsidiary The Diagnostic Centers Signs First New Client

FORT WORTH, TX -- (Marketwired) -- 11/02/17 -- AppYea Inc. (OTC PINK: APYP) announced today that its subsidiary The Diagnostic Centers has signed its first new client, Pacific Pain & Regenerative Medicine, with locations in Los Angeles and Irvine, California and has started shipping PGx samples for testing.

Under this new agreement, Pacific Pain & Regenerative Medicine guarantees a minimum of 20 PGx tests per month which will generate between $20,000 and $40,000 per month of revenue to the Company, depending on the test. Pharmacogenetic (PGx) testing is used for determining how an individual will respond to a particular medicine. Clinicians use PGx testing to provide personalized medicine rather than using the population-based or one size fits all approach. PGx testing may also improve medication adherence.

PGx testing provides insight into a patient's metabolic pathways. Knowing which pathways are functioning normally or abnormally allows a physician to prescribe medications as intended by the drug manufacturer, select the most appropriate dose, and even the best drug for the patient.

"This is the first step in signing up doctor groups and clinics. As we demonstrate successful and timely testing, it will allow us to add toxicology testing for their patents as well. Based on the number of samples per month we will see a significant change in the way we do business as a company," Douglas McKinnon, AppYea's CEO, stated. "If we manage 1000 tests per month for doctor groups we are looking at a completely different company."


AppYea Announces Sales and Marketing Team for Its Diagnostic Centers Inc.

FORT WORTH, TX -- (Marketwired) -- 09/20/17 -- APPYEA Inc. (OTC PINK: APYP) announced on August 14th, 2017 that it formed a new subsidiary, The Diagnostic Centers Inc., to focus on marketing certain products and services to healthcare providers.

The Diagnostic Centers Inc. has partnered with two new sales professionals to help build its team. Frank Molak will head up the new sales and marketing division and provide support to its employees and guidance. Frank helped launch the pharmacy discount card company WaterTree Health that is now a nationally recognized pharmacy discount program.

We also added Josh Booty who not only played in the MLB for several years including playing third base for the 1997 World Series Champion team the Florida Marlins, but also played in the NFL for the Seahawks, Browns and Raiders. "His commitment to excellence is what attracted us to hiring this individual," stated Douglas McKinnon, CEO of AppYea. After Josh's playing days, he has excelled in business development and consulting for many companies including Athletes 1st, a football sports agency. Josh has also worked with FoxSports, FOXSports.com, ESPN, ESPN Radio, SiriusXM, GridironNow.com, CBS Sports and MLB Network as a radio, internet and TV personality.

Formerly the spokesperson for TrueMRI in Beverly Hills, California, his focus now is to use the contacts that he has developed in both sports and business to drive sales and marketing to this national medical laboratory services marketing company.

Doug McKinnon stated, "I am pleased to welcome these talented individuals to our sales and marketing team as the company takes on exciting new developments with its subsidiary."

Current news regarding Appyea and the development of New APPS

AppYea Launches Three New Apps on Google Play

FORT WORTH, TX -- (Marketwired) -- 10/17/17 -- AppYea Inc (OTC PINK: APYP) announced today that it has released two new gaming apps and one pharmaceutical savings app on Google Play for the Android systems and will soon release the games on Apple's iTunes for the iPhone and iOS Platform.

The two new gaming apps are kid friendly and will be available in the in-app purchasing system for download. The first game is titled Duck Quest and is a challenging game where the objective is to fly a funny duck avoiding treacherous obstacles. The longer you stay in the air the more points you accumulate. A fun and engaging experience that will have you hooked in no time.

The second kid friendly game is Ball Bearing Racer, a simple but fun racing simulation where you can pick your character and race through large cities, avoiding obstacles in your path and earning rewards along the way.

Lastly with the new app Cheap RX, you can immediately save money on prescriptions for the entire family; you can save an estimated 10% to 85% on most generic and brand name prescriptions. There is no cost to use this app and you and your family can use it as often as you like at any of the 60,000 participating pharmacies nationwide! Revenues will come from advertising and or charging for add-ons or the app itself.

"Although the company previously announced that it has entered the healthcare services market, we will continue adding new apps and redeveloping the mobile applications that we have in our pipeline in an effort to drive revenues to the company," stated AppYea's CEO Douglas McKinnon.

According to Statista Inc. who tracks the global mobile application market, in 2015, global mobile app revenues amounted to 69.7 billion U.S. dollars. In 2020, mobile apps are projected to generate 188.9 billion U.S. dollars in revenues via app stores and in-app advertising.

CEO Mckinnon just trashed commons here... what a POS.... been waiting over a year for this sob to do something other than pay his salary.... 


The Board of Directors and the Majority Stockholders have approved, an increase in our authorized common shares from 750,000,000 to 1,500,000,000. The Board of Directors has determined that this increase in the Company’s authorized shares is advisable and in the best interests of us and our stockholders. 
Best intrest of who???? Not commons that's for sure



Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
APYP News: Quarterly Report (10-q) 11/14/2018 02:54:28 PM
APYP News: Annual Report (10-k) 10/15/2018 05:25:51 PM
APYP News: Notification That Annual Report Will Be Submitted Late (nt 10-k) 10/01/2018 04:10:27 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#18960  Sticky Note $APYP 3 Months Chart http://www.stockscores.c $Pistol Pete$ 12/10/17 07:50:46 PM
#18940  Sticky Note AppYea Signs Sales and Marketing Agreement with Syncier BioTech YeralHax 12/08/17 02:48:14 PM
#18510  Sticky Note New CEO Mckinnon just trashed commons here... what HDOGTX 06/06/17 05:46:27 PM
#20440   IMO, reverse split first, probably 750 to 1, plutoniumimplosion 01/19/19 11:35:30 AM
#20439   Reverse! Fufat 01/19/19 11:05:55 AM
#20438   Cheap CEO Doug has destroyed this ticker by Fufat 01/19/19 11:00:19 AM
#20437   Me!? F no. He’s a lousy piece YeralHax 01/19/19 02:17:10 AM
#20436   Has CEO Doug worn you out yet? plutoniumimplosion 01/18/19 10:55:37 PM
#20435   Cheap CEO Doug has destroyed this ticker by YeralHax 01/16/19 02:36:49 PM
#20434   Have you had enough yet? plutoniumimplosion 01/15/19 09:53:30 AM
#20433   When is BLULISH going to pump this PoS again? YeralHax 01/14/19 09:23:33 AM
#20432   Well that makes perfect sense. It is, Peggy 01/12/19 10:46:01 AM
#20431   Guess I’ll bid 1s. ThoughtPower 01/11/19 01:36:53 PM
#20430   hell no m_m007 01/09/19 03:55:32 PM
#20429   spank the ask then lol RammageRaul 01/09/19 03:25:50 PM
#20428   No doubt about that YeralHax 01/09/19 01:29:37 PM
#20427   very close to no Bid, its coming m_m007 01/09/19 12:56:48 PM
#20426   Suckers? Hundreds of millions are going to get dumped YeralHax 01/06/19 11:10:42 PM
#20425   Keep hitting my 1zzz suckers. $$$ Eyeofthetiger69 01/06/19 09:50:48 PM
#20424   1z will be golden GOLDBUFFALO 01/03/19 05:39:58 PM
#20423   A little early for tax loss selling. YeralHax 01/03/19 12:46:42 PM
#20422   Well then ThoughtPower 01/03/19 12:17:41 PM
#20420   So if there is a pump, that means YeralHax 01/02/19 09:30:14 PM
#20419   that's all we need a pump. fake or NewTrader2017 01/02/19 09:11:37 PM
#20418   Doug will not come through, he’s a chump YeralHax 01/02/19 05:46:47 PM
#20417   1.3B on a MJ ticker @.0002 ? Any NewTrader2017 01/02/19 05:18:48 PM
#20416   Show me MJ news! $$$ Eyeofthetiger69 12/30/18 08:37:06 PM
#20415   Reverse! plutoniumimplosion 12/29/18 08:40:23 PM
#20414   Yea thats going to do it, lmao m_m007 12/27/18 10:29:22 AM
#20413   doubt it, Giangy just added it to his favs RammageRaul 12/26/18 04:30:58 PM
#20412   No bid by Friday m_m007 12/26/18 10:03:48 AM
#20411   With no news and the company diluting. Doubt m_m007 12/21/18 03:16:45 PM
#20410   wrong! I rode s.f..r from .0015 to 01 RammageRaul 12/21/18 03:16:35 PM
#20409   01 maybe not but def .00 RammageRaul 12/21/18 03:15:00 PM
#20408   Not with this OS. SFOR was a YeralHax 12/21/18 03:06:59 PM
#20407   Not with this pos m_m007 12/21/18 03:03:12 PM
#20406   I’ll take me some 1zzzz. Eyeofthetiger69 12/21/18 02:55:11 PM
#20405   s..f..o..r from 0001 to .02 I can name RammageRaul 12/21/18 02:29:49 PM
#20404   .0001 no big deal! Lol YeralHax 12/21/18 02:23:08 PM
#20403   6000$ bucks worth of dumpage no big deal, RammageRaul 12/21/18 01:59:57 PM
#20402   Def going to no bid, seen it too plutoniumimplosion 12/21/18 01:55:47 PM
#20401   Def going to no bid, seen it too Goldenchild777 12/21/18 01:53:17 PM
#20400   Looks like the company will dump and take m_m007 12/21/18 01:51:06 PM
#20399   diluting POS SCAM....IMO Goldenchild777 12/21/18 01:49:41 PM
#20398   You where saying m_m007 12/21/18 01:47:05 PM
#20397   they are going to be a good flip GOLDBUFFALO 12/21/18 01:39:52 PM
#20396   Im not even bidding 1s ..waste of time RammageRaul 12/21/18 10:20:32 AM
#20395   good luck getting 1s lolol RammageRaul 12/21/18 10:18:57 AM
#20394   Looks like no more 2’s. Serving 0001 and 0003’s m_m007 12/21/18 09:58:02 AM
#20393   This just holding by a tread. Lmao m_m007 12/20/18 02:31:36 PM
#20392   I mean look at ZNGY. He was USAR/chro... YeralHax 12/19/18 10:40:59 PM
#20391   correct...Do-Nothing Doug is infamous! artmaniac 12/19/18 09:46:38 PM
#20390   Doug is a slug! Line your pockets dirtwad! Raphael De La Ghetto 12/18/18 11:32:34 PM